The Department of Health and Human Services Indian Health Service awarded a $112,400.00 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of reagents, test kits, instruments, and testing platforms to support the agency's clinical diagnostic programs. No set-aside was used for this award. The contract has a period of performance through December 31, 2021. Cepheid is a subsidiary of the Danaher...
This is a firm fixed-price delivery order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $29,071.25 contract is for the provision of Cepheid's diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to support clinical testing programs serving the IHS patient population. This award does not have a...
Cepheid has been awarded a $100,000 firm fixed price BPA call contract by the Department of Health and Human Services Indian Health Service to provide molecular diagnostic solutions. As the prime contractor, Cepheid will supply its range of diagnostic testing equipment, reagents, consumables, and associated maintenance and support services. No set-aside designation was used for this award. Cepheid is a manufacturer of in vitro diagnostic tests and platforms for infectious diseases and genetic...
This firm fixed-price purchase order was awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $205,750.00 contract is for the provision of laboratory testing supplies, with a period of performance through November 10, 2024. Cepheid is a prime contractor experienced in supplying diagnostic equipment, reagents, and consumables to federal agencies, including the...
The Department of Health and Human Services Indian Health Service awarded a delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, on September 2, 2021. The contract, which does not have a set-aside designation, has a potential value of $170,000.00 and a completion date of July 27, 2022. Cepheid, a subsidiary of Danaher Corporation, provides a range of goods and services related to diagnostic testing equipment, reagents, and consumables, as well as...
The U.S. Indian Health Service awarded a $168,475.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the administrative modification to extend the period of performance to December 31, 2025. Cepheid provides comprehensive molecular diagnostic technologies to various federal agencies, including the Department of Veterans Affairs (VA), Indian Health Service (IHS), and Defense...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $416,991.94, is for the supply of CEPHEID diagnostic products and has an ultimate completion date of July 30, 2025. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. Cepheid is the prime contractor...
This federal contract award to Cepheid, a for-profit manufacturer of diagnostic solutions, is for the purchase of analyzers, related equipment, supplies, and services to support COVID-19 testing and patient care for the Department of Health and Human Services (HHS) Indian Health Service. The $297,270.00 fixed-price delivery order does not utilize a set-aside designation. As the prime contractor, Cepheid will provide reagents, test kits, instruments, and testing platforms to the Indian Health...
This is a firm fixed-price purchase order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for a CEPHEID SERVICE AGREEMENT to reinstate service and provide a base year plus three option years, with a ceiling value of $32,600.00. The contract supports the Indian Health Service's clinical testing programs by providing Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance...
The Department of Health and Human Services Indian Health Service has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID SUPPLIES/REAGENTS, CRSU. The contract, which does not have a set-aside designation, has a potential value of $797,528.50 and a completion date of February 2, 2024. Cepheid is the prime contractor and will provide the required diagnostic equipment, reagents, and...